Immunogenic Composition with Electrostatic Dendritic Cell Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunogenic compositions fail to effectively target dendritic cells, which are crucial for generating an immune response, as they do not utilize electrostatic interactions between antigens and dendritic cell ligands, limiting their ability to induce robust antibody and cell-mediated responses, especially in viral infections and cancer.
Innovation Solution
Development of immunogenic compositions that electrostatically associate a polypeptide antigen with a dendritic cell targeting component, where the antigen has a negatively charged region and the targeting component has a positively charged group with branched peptides covalently attached to a Toll-like receptor ligand, such as Pam2Cys, facilitating targeted delivery to dendritic cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional immunogenic compositions are used, then the composition structure is simple, but the ability to target dendritic cells is insufficient
Solution Approach 1:
The patent combines an antigen with a dendritic cell targeting component to form an immunogenic composition. The targeting component includes a cationic peptide sequence that electrostatically interacts with the negatively charged antigen, creating a composite structure that simultaneously provides antigenicity and dendritic cell targeting capability.
Solution Approach 2:
The patent utilizes electrostatic charge parameters to achieve targeted delivery. The cationic peptide sequence (with positive charge) interacts with the negatively charged antigen through electrostatic attraction, creating a charge-based targeting mechanism that enhances dendritic cell uptake without requiring complex structural modifications.
2Reliability
If electrostatic association is used between antigen and dendritic cell targeting component, then the immune response is enhanced, but the interaction mechanism becomes more complex
Solution Approach 1:
The patent replaces complex mechanical or chemical conjugation methods with electrostatic interaction mechanisms. The cationic peptide sequence naturally interacts with the negatively charged antigen through electrostatic attraction, providing a simpler and more versatile binding mechanism that enhances immune response without requiring complex molecular conjugation.
3Device complexity
If the antigen is associated with dendritic cell targeting component by electrostatic interaction only, then the composition is simpler, but the stability of association may be reduced
Solution Approach 1:
The patent optimizes the electrostatic interaction by carefully selecting the cationic peptide sequence and its charge density. The peptide sequence (with multiple basic amino acids) provides sufficient positive charge to maintain stable association with the negatively charged antigen through electrostatic attraction, while keeping the overall composition relatively simple.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The electrostatic association enhances the immunogenicity of antigens by eliciting strong antibody and cell-mediated responses, as demonstrated by increased antibody titers and activated CD8+ T cells, indicating improved immune response efficacy.
Implementation Method 1
the polypeptide antigen comprises a negatively charged region and wherein the dendritic cell targeting component comprises a positively charged group... wherein the negatively charged region of antigen is electrostatically associated with the positively charged group of the dendritic cell targeting component
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
The present invention provides an immunogenic composition comprising an antigen and a dendritic cell targeting component. A charged group is covalently attached to a dendritic cell ligand and is electrostatically associated with the dendritic cell targeting component.